YORK, Pa., Jan. 29, 2014 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS) announced today that it intends to release its financial results for the fiscal 2014 second quarter ended December 31, 2013 after market trading ends on Monday, February 3, 2014.

Management has scheduled a conference call for 4:30 p.m. U.S. EST on Monday, February 3, 2014 (Tuesday, February 4, 2014 at 8:30 a.m. AEDT), to review the Company's financial results, commercial partnerships, and future outlook. The conference call will be broadcast over the Internet as a "live" listen only Webcast. To listen, please go to: http://ir.unilife.com/events.cfm. Listeners are urged to login approximately 20 minutes before the conference call is scheduled to begin in order to register, as well as download and install any necessary audio software. An archive of the webcast will be available on the Company's website.

About Unilife Corporation

Unilife Corporation (NASDAQ:UNIS / ASX: UNS) is a U.S. based developer and commercial supplier of injectable drug delivery systems. Unilife's broad portfolio includes prefilled syringes with automatic needle retraction, drug reconstitution delivery systems, auto-injectors, wearable injectors, intraocular delivery systems and novel delivery systems. Each of these innovative, differentiated technology platforms can be customized to address specific customer, drug and patient requirements. Unilife's global headquarters and state-of-the-art manufacturing facilities are located in York, PA. For more information, please visit www.unilife.com or download the Unilife IRapp on your iPhone, iPad or Android device.

General: UNIS-G 



    Investor Contacts (US):            Analyst Enquiries    Investor Contacts
                                                            (Australia)

    Todd Fromer / Garth Russell        Lynn Pieper         Jeff Carter

    KCSA Strategic Communications      Westwicke Partners  Unilife Corporation

    P: + 1 212-896-1215 / 212-896-1250 P: + 1 415-202-5678 P: + 61 2 8346 6500

SOURCE Unilife Corporation